LMNA mutation position predicts organ system involvement in laminopathies

Clinical Genetics

Volumn 68, Issue 1, 2005, Pages 31-34

  Hegele, Robert A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Cardiovascular disease; Genotype association; Hierarchical cluster analysis; Neurological disease; Nuclear envelope; Phenotype

Indexed keywords

LAMIN A; LAMIN C;

ARTICLE; CELL NUCLEUS MEMBRANE; GENE; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; HIERARCHICAL CLUSTER ANALYSIS; HUMAN; LAMINOPATHY; LMNA GENE; METHODOLOGY; MONOGENIC DISORDER; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; LAMIN TYPE A; MUSCULAR DISEASES; MUTATION; NUCLEAR LOCALIZATION SIGNALS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 20944446928     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2005.00447.x     Document Type: Article

References (13)

1. Freimer N, Sabatti C. The human phenome project. Nat Genet 2003: 34: 15-21.
2. Scriver CR. After the genome - the phenome? J Inherit Metab Dis 2004: 27: 305-317.
3. Hartikka H, Kuurila K, Korkko J, Kaitila I, Grenman R, Pynnonen S. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients. Hum Mutat 2004: 24: 147-154.
4. Terlato NJ, Cox GF. Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature. Genet Med 2003: 5: 286-294.
5. Hocking LJ, Lucas GJ, Daroszewska A, Cundy T, Nicholson GC, Donath J et al. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res 2004: 19: 1122-1127.
6. Biggin A, Holman K, Brett M, Bennetts B, Ades L. Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy. Hum Mutat 2004: 23: 99.
7. Macias-Gomez NM, Megarbane A, Leal-Ugarte E, Rodriguez-Rojas LX, Barros-Nunez P. Diastrophic dysplasia and atelosteogenesis type II as expression of compound heterozygosis: first report of a Mexican patient and genotype-phenotype correlation. Am J Med Genet 2004: 129A: 190-192.
8. Pey AL, Desviat LR, Gamez A, Ugarte M, Perez B. Phenylketonuria: genotype-pheno type correlations based on expression analysis of structural and functional mutations in PAH. Hum Mutat 2003: 21: 370-378.
9. Waters PJ. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat 2003: 21: 357-369.
10. Herrmann H, Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular scaffolds. Amin Rev Biochem 2004: 73: 749-789.
11. Stierle V, Couprie J, Ostlund C, Krimm I, Zinn-Justin S, Hossenlopp P et al. The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 2003: 42: 4819-4828.
12. Worman HJ, Courvalin JC. How do mutations in lamins A and C cause disease? J Clin Invest 2004: 113: 349-351.
13. Garg A, Speckman RA, Bowcock AM. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med 2002: 112: 549-555.